Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitis.
BACKGROUND: The optimal time to initiate antiretroviral therapy (ART) in human immunodeficiency virus (HIV)-associated tuberculous meningitis is unknown. METHODS: We conducted a randomized, double-blind, placebo-controlled trial of immediate versus deferred ART in patients with HIV-associated tuber...
Autors principals: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
2011
|